Finance

Lists
Why is CRBP down 7,74%?
Dive Deeper
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
4,41 US$
-7,74%
(-0,37) 1D
4,40 US$
-0,29% (-0,013)
After hours
Closed: 14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
4,72 US$
High
4,82 US$
Low
4,37 US$
Mkt. cap
85,30 მლნ.
Avg. vol.
1,21 მლნ.
Volume
1,34 მლნ.
52-wk high
20,56 US$
52-wk low
4,37 US$
EPS
-6,17 US$
Beta
2,63
Shares outstanding
19,34 მლნ.
No. of employees
36
Open
4,72 US$
High
4,82 US$
Low
4,37 US$
Mkt. cap
85,30 მლნ.
Avg. vol.
1,21 მლნ.
Volume
1,34 მლნ.
52-wk high
20,56 US$
52-wk low
4,37 US$
EPS
-6,17 US$
Beta
2,63
Shares outstanding
19,34 მლნ.
No. of employees
36
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
Founded1 იან. 2009
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current 4,41 US$
48,00 US$ (+988,44%)
Average
36,67 US$ (+731,52%)
Lowest
30,00 US$ (+580,27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
30,00 US$
+580,3%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
35,00 US$
+693,7%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
38,00 US$
+761,7%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
33,00 US$
+648,3%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
36,00 US$
+716,3%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
48,00 US$
+988,4%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
48,00 US$
+988,4%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
45,00 US$
+920,4%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
38,00 US$
+761,7%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
33,00 US$
+648,3%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
28,00 US$
+534,9%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
20,86 მლნ.
18,41 მლნ.
19,82 მლნ.
31,18 მლნ.
Cost of revenue
20,86 მლნ.
18,41 მლნ.
19,82 მლნ.
31,18 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,56 მლნ.
3,56 მლნ.
4,48 მლნ.
5,02 მლნ.
Operating expense
3,56 მლნ.
3,56 მლნ.
4,48 მლნ.
5,02 მლნ.
Total operating expenses
24,42 მლნ.
21,97 მლნ.
24,30 მლნ.
36,19 მლნ.
Operating income
-24,42 მლნ.
-21,97 მლნ.
-24,30 მლნ.
-36,19 მლნ.
Other non operating income
-50,00 ათ.
-1,10 მლნ.
-67,00 ათ.
-11,00 ათ.
EBT including unusual items
-23,34 მლნ.
-20,56 მლნ.
-22,97 მლნ.
-35,04 მლნ.
EBT excluding unusual items
-23,34 მლნ.
-21,66 მლნ.
-22,97 მლნ.
-35,04 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23,34 მლნ.
-20,56 მლნ.
-22,97 მლნ.
-35,04 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-1,90
-1,25
-1,23
-1,81
Interest and investment income
1,12 მლნ.
1,41 მლნ.
1,40 მლნ.
1,16 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,12 მლნ.
1,41 მლნ.
1,40 მლნ.
1,16 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-24,37 მლნ.
-21,92 მლნ.
-24,26 მლნ.
-36,14 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები